Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Sponsor: Rigshospitalet, Denmark
This NA trial investigates Beta Enolase Deficiency and Carbohydrate Metabolism, Inborn Errors and is currently ongoing. Rigshospitalet, Denmark leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — Nov 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .